Cladribine — still important in era of new therapies

Bartosz Puła

Vol 55, No 5 (2024)

Editorial

Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

Ahmet Kaya, Mehmet Ali Erkurt, Irfan Kuku, Emin Kaya, Ilhami Berber, Ahmet Sarıcı, Zehra Bozdağ, Soykan Biçim, Süleyman Arslan, Fatma Hilal Yagın

Vol 55, No 5 (2024)

Original research article

Managing post-transplant relapse in FLT3-mutated AML with gilteritinib

Zuzanna M. Rzetelska, Andrzej Szczepaniak, Lidia Gil

Vol 55, No 5 (2024)

Clinical vignette

Changes in the nutritional status of children with cancer depending on clinical, demographic and social factors

Anna Milaniuk, Katarzyna Drabko

Vol 55, No 5 (2024)

Original research article

DAC and CLAM are equally effective as early second induction in newly diagnosed AML patients with persistent leukemia in early bone marrow evaluation – a retrospective analysis of Polish Adult Leukemia Group

Kamil Brzozowski, Agnieszka Pluta, Martyna Włodarczyk, Grzegorz Helbig, Małgorzata Raźny, Tomasz Gromek, Marek Hus, Marta Sobas, Łukasz Bołkun, Elżbieta Patkowska, Andrzej Szczepaniak, Krzysztof Gawroński, Janusz Hałka, Edyta Cichocka, Elżbieta Wiater, Agata Obara, Ewa Wawrzyniak, Agnieszka Wierzbowska

Vol 55, No 5 (2024)

Original research article

A breakthrough in lymphoma therapy

Bartosz Puła

Vol 55, No 4 (2024)

Editorial

Nicotine addiction and an elevated cholesterol level exhibit negative effects on platelet activation in patients with chronic Buerger’s disease

Aleksandra Nowaczyńska, Tomasz Zubilewicz, Bożena Sokołowska, Piotr Terlecki, Agnieszka Szymczyk, Iwona Hus

Vol 55, No 4 (2024)

Original research article

Acute intermittent porphyria: a diagnostic challenge.

Karol Bigosiński, Maciej Dubaj, Aneta Szudy-Szczyrek, Marek Hus

Vol 55, No 4 (2024)

Clinical vignette

Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin’s lymphoma.

Karolina Chromik, Aleksandra Spyra, Paulina Repa, Grzegorz Helbig

Vol 55, No 4 (2024)

Clinical vignette

Therapy-related myeloid malignancies in patients with multiple myeloma.

Tadeusz Kubicki, Monika Adamska, Krzysztof Żyłka, Dominik Dytfeld, Lidia Gil

Vol 55, No 4 (2024)

Review article

Effective treatment of autoimmune thrombocytopenia with rituximab in CLL patient undergoing therapy with acalabrutinib

Elżbieta Iskierka-Jażdżewska, Tadeusz Robak

Vol 55, No 4 (2024)

Clinical vignette

Ischemic stroke as a consequence of acute hemolytic anemia following arsenic poisoning.

Malgorzata Elżbieta Poniatowska, Izabela Molka, Tomasz Janus, Barbara Potocka-Banaś, Krzysztof Kowalik, Marta Niewiadomska, Justyna Jabłońska-Odroniec, Katarzyna Brzeźnikiewicz-Janus

Vol 55, No 4 (2024)

Clinical vignette

Tabelecleucel: a new therapeutic option in refractory EBV-PTLD

Jan Styczyński, Monika Pogorzała, Jagoda Sadlok, Magdalena Woźniak

Vol 55, No 4 (2024)

Review article

Bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma.

Michał Danecki, Wojciech Jurczak

Vol 55, No 4 (2024)

Review article

A helping hand

Bartosz Pula

Vol 55, No 3 (2024)

Editorial